Search results

117 items matching your search terms.
Filter the results.
Item type













New items since



Sort by relevance · date (newest first) · alphabetically
Preventing HPV might lower risk of HIV infection in men
Men infected with human papillomavirus (HPV) are at greater risk of becoming infected with human immunodeficiency virus (HIV) than men who are not HPV positive, according to researchers at the University of North Carolina at Chapel Hill.
Located in Vital Signs / 2010 / Vital Signs - May 13, 2010
Preventing the spread of HIV/AIDS with humanized BLT mice
A new study from the University of North Carolina at Chapel Hill School of Medicine further validates the use of humanized BLT mice in the fight to block HIV transmission.
Located in News / 2011 / May
Progress in AIDS battle, thanks to UNC study
A UNC-led research study has made a major discovery in efforts to halt the spread of HIV, the virus that causes AIDS.
Located in Vital Signs / 2011 / May 12
Proof-of-Concept HIV Immunotherapy Study Passes Phase 1 Safety Trial
Julia Sung, MD, assistant professor of medicine in the Division of Infectious Diseases, has proven the safety of a new immunotherapy to re-educate the body’s immune system to better fight HIV infection. The results were recently published in the journal Molecular Therapy.
Located in Vital Signs / 2018 / Sept. 27
Protein changes in immune system determine ability to control HIV without drugs
A small number of people with HIV have the ability to control the infection without drugs. New results from a multinational study involving more than 300 investigators at over 200 institutions around the world may have found a genetic basis to explain how this happens.
Located in News / 2010 / November
Registration now open for UNC HIV Care 2009: Antiretroviral Therapy, Hepatitis B/C, Addiction, and Adherence
The purpose of this conference is to provide an update on treatment of Hepatitis B and C, drug addiction and adherence.
Located in Vital Signs / 2009 / March
Registration now open for UNC HIV Care 2009: Antiretroviral Therapy, Hepatitis B/C, Addiction, and Adherence
The purpose of this conference is to provide an update on treatment of Hepatitis B and C, drug addiction and adherence.
Located in Vital Signs / 2009 / April
Registration now open for UNC HIV Care 2009: Antiretroviral Therapy, Hepatitis B/C, Addiction, and Adherence
The purpose of this conference is to provide an update on treatment of Hepatitis B and C, drug addiction and adherence.
Located in Vital Signs / 2009 / April
Researchers Discuss Challenges, Successes of HIV Cure Research in Science
A better understanding of HIV latency is the key to eradicating the virus researchers at the University of North Carolina and partner institutions write in a perspective in the journal Science.
Located in News / 2016 / July
Researchers identify timeline for HIV replication in the brain
A new study in PLoS Pathogens shows that HIV can infect the brain early on and should be combated as soon as possible with antiretroviral therapy to limit risk of dementia
Located in News / 2015 / March